Intra-articular injection of a substance P inhibitor affects gene expression in a joint contracture model

Mark E. Morrey, Joaquin Sanchez-Sotelo, Eric A. Lewallen, Kai Nan An, Diane E. Grill, Scott P. Steinmann, Jie J. Yao, Christopher G. Salib, William H. Trousdale, Nicolas Reina, Hilal D Maradit Kremers, David G. Lewallen, Andre J van Wijnen, Matthew Abdel

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Substance P (SP), a neurotransmitter released after injury, has been linked to deregulated tissue repair and fibrosis in musculoskeletal tissues and other organs. Although SP inhibition is an effective treatment for nausea, it has not been previously considered as an anti-fibrotic therapy. Although there are extensive medical records of individuals who have used SP antagonists, our analysis of human registry data revealed that patients receiving these antagonists and arthroplasty are exceedingly rare, thus precluding a clinical evaluation of their potential effects in the context of arthrofibrosis. Therefore, we pursued in vivo studies to assess the effect of SP inhibition early after injury on pro-fibrotic gene expression and contractures in an animal model of post-traumatic joint stiffening. Skeletally mature rabbits (n=24) underwent surgically induced severe joint contracture, while injected with either fosaprepitant (a selective SP antagonist) or saline (control) early after surgery (3, 6, 12, and 24h). Biomechanical testing revealed that differences in mean contracture angles between the groups were not statistically significant (P=0.27), suggesting that the drug neither mitigates nor exacerbates joint contracture. However, microarray gene expression analysis revealed that mRNA levels for proteins related to cell signaling, pro-angiogenic, pro-inflammatory, and collagen matrix production were significantly different between control and fosaprepitant treated rabbits (P<0.05). Hence, our study demonstrates that inhibition of SP alters expression of pro-fibrotic genes in vivo. This finding will motivate future studies to optimize interventions that target SP to reduce the formation of post-traumatic joint contractures.

Original languageEnglish (US)
JournalJournal of Cellular Biochemistry
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Intra-Articular Injections
Contracture
Substance P
Gene expression
Joints
fosaprepitant
Gene Expression
Tissue
Rabbits
Cell signaling
Arthroplasty
Wounds and Injuries
Microarrays
Surgery
Nausea
Medical Records
Neurotransmitter Agents
Registries
Animals
Fibrosis

Keywords

  • Animal model
  • Microarray
  • Post-traumatic joint contracture

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Intra-articular injection of a substance P inhibitor affects gene expression in a joint contracture model. / Morrey, Mark E.; Sanchez-Sotelo, Joaquin; Lewallen, Eric A.; An, Kai Nan; Grill, Diane E.; Steinmann, Scott P.; Yao, Jie J.; Salib, Christopher G.; Trousdale, William H.; Reina, Nicolas; Maradit Kremers, Hilal D; Lewallen, David G.; van Wijnen, Andre J; Abdel, Matthew.

In: Journal of Cellular Biochemistry, 01.01.2017.

Research output: Contribution to journalArticle

Morrey, ME, Sanchez-Sotelo, J, Lewallen, EA, An, KN, Grill, DE, Steinmann, SP, Yao, JJ, Salib, CG, Trousdale, WH, Reina, N, Maradit Kremers, HD, Lewallen, DG, van Wijnen, AJ & Abdel, M 2017, 'Intra-articular injection of a substance P inhibitor affects gene expression in a joint contracture model', Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.26256
Morrey, Mark E. ; Sanchez-Sotelo, Joaquin ; Lewallen, Eric A. ; An, Kai Nan ; Grill, Diane E. ; Steinmann, Scott P. ; Yao, Jie J. ; Salib, Christopher G. ; Trousdale, William H. ; Reina, Nicolas ; Maradit Kremers, Hilal D ; Lewallen, David G. ; van Wijnen, Andre J ; Abdel, Matthew. / Intra-articular injection of a substance P inhibitor affects gene expression in a joint contracture model. In: Journal of Cellular Biochemistry. 2017.
@article{98feed9bb35c4aeaab5068a21cfbe45c,
title = "Intra-articular injection of a substance P inhibitor affects gene expression in a joint contracture model",
abstract = "Substance P (SP), a neurotransmitter released after injury, has been linked to deregulated tissue repair and fibrosis in musculoskeletal tissues and other organs. Although SP inhibition is an effective treatment for nausea, it has not been previously considered as an anti-fibrotic therapy. Although there are extensive medical records of individuals who have used SP antagonists, our analysis of human registry data revealed that patients receiving these antagonists and arthroplasty are exceedingly rare, thus precluding a clinical evaluation of their potential effects in the context of arthrofibrosis. Therefore, we pursued in vivo studies to assess the effect of SP inhibition early after injury on pro-fibrotic gene expression and contractures in an animal model of post-traumatic joint stiffening. Skeletally mature rabbits (n=24) underwent surgically induced severe joint contracture, while injected with either fosaprepitant (a selective SP antagonist) or saline (control) early after surgery (3, 6, 12, and 24h). Biomechanical testing revealed that differences in mean contracture angles between the groups were not statistically significant (P=0.27), suggesting that the drug neither mitigates nor exacerbates joint contracture. However, microarray gene expression analysis revealed that mRNA levels for proteins related to cell signaling, pro-angiogenic, pro-inflammatory, and collagen matrix production were significantly different between control and fosaprepitant treated rabbits (P<0.05). Hence, our study demonstrates that inhibition of SP alters expression of pro-fibrotic genes in vivo. This finding will motivate future studies to optimize interventions that target SP to reduce the formation of post-traumatic joint contractures.",
keywords = "Animal model, Microarray, Post-traumatic joint contracture",
author = "Morrey, {Mark E.} and Joaquin Sanchez-Sotelo and Lewallen, {Eric A.} and An, {Kai Nan} and Grill, {Diane E.} and Steinmann, {Scott P.} and Yao, {Jie J.} and Salib, {Christopher G.} and Trousdale, {William H.} and Nicolas Reina and {Maradit Kremers}, {Hilal D} and Lewallen, {David G.} and {van Wijnen}, {Andre J} and Matthew Abdel",
year = "2017",
month = "1",
day = "1",
doi = "10.1002/jcb.26256",
language = "English (US)",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Intra-articular injection of a substance P inhibitor affects gene expression in a joint contracture model

AU - Morrey, Mark E.

AU - Sanchez-Sotelo, Joaquin

AU - Lewallen, Eric A.

AU - An, Kai Nan

AU - Grill, Diane E.

AU - Steinmann, Scott P.

AU - Yao, Jie J.

AU - Salib, Christopher G.

AU - Trousdale, William H.

AU - Reina, Nicolas

AU - Maradit Kremers, Hilal D

AU - Lewallen, David G.

AU - van Wijnen, Andre J

AU - Abdel, Matthew

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Substance P (SP), a neurotransmitter released after injury, has been linked to deregulated tissue repair and fibrosis in musculoskeletal tissues and other organs. Although SP inhibition is an effective treatment for nausea, it has not been previously considered as an anti-fibrotic therapy. Although there are extensive medical records of individuals who have used SP antagonists, our analysis of human registry data revealed that patients receiving these antagonists and arthroplasty are exceedingly rare, thus precluding a clinical evaluation of their potential effects in the context of arthrofibrosis. Therefore, we pursued in vivo studies to assess the effect of SP inhibition early after injury on pro-fibrotic gene expression and contractures in an animal model of post-traumatic joint stiffening. Skeletally mature rabbits (n=24) underwent surgically induced severe joint contracture, while injected with either fosaprepitant (a selective SP antagonist) or saline (control) early after surgery (3, 6, 12, and 24h). Biomechanical testing revealed that differences in mean contracture angles between the groups were not statistically significant (P=0.27), suggesting that the drug neither mitigates nor exacerbates joint contracture. However, microarray gene expression analysis revealed that mRNA levels for proteins related to cell signaling, pro-angiogenic, pro-inflammatory, and collagen matrix production were significantly different between control and fosaprepitant treated rabbits (P<0.05). Hence, our study demonstrates that inhibition of SP alters expression of pro-fibrotic genes in vivo. This finding will motivate future studies to optimize interventions that target SP to reduce the formation of post-traumatic joint contractures.

AB - Substance P (SP), a neurotransmitter released after injury, has been linked to deregulated tissue repair and fibrosis in musculoskeletal tissues and other organs. Although SP inhibition is an effective treatment for nausea, it has not been previously considered as an anti-fibrotic therapy. Although there are extensive medical records of individuals who have used SP antagonists, our analysis of human registry data revealed that patients receiving these antagonists and arthroplasty are exceedingly rare, thus precluding a clinical evaluation of their potential effects in the context of arthrofibrosis. Therefore, we pursued in vivo studies to assess the effect of SP inhibition early after injury on pro-fibrotic gene expression and contractures in an animal model of post-traumatic joint stiffening. Skeletally mature rabbits (n=24) underwent surgically induced severe joint contracture, while injected with either fosaprepitant (a selective SP antagonist) or saline (control) early after surgery (3, 6, 12, and 24h). Biomechanical testing revealed that differences in mean contracture angles between the groups were not statistically significant (P=0.27), suggesting that the drug neither mitigates nor exacerbates joint contracture. However, microarray gene expression analysis revealed that mRNA levels for proteins related to cell signaling, pro-angiogenic, pro-inflammatory, and collagen matrix production were significantly different between control and fosaprepitant treated rabbits (P<0.05). Hence, our study demonstrates that inhibition of SP alters expression of pro-fibrotic genes in vivo. This finding will motivate future studies to optimize interventions that target SP to reduce the formation of post-traumatic joint contractures.

KW - Animal model

KW - Microarray

KW - Post-traumatic joint contracture

UR - http://www.scopus.com/inward/record.url?scp=85034631807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034631807&partnerID=8YFLogxK

U2 - 10.1002/jcb.26256

DO - 10.1002/jcb.26256

M3 - Article

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

ER -